Cargando…

Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials

BACKGROUND: Intensive blood pressure (BP) treatment can avert cardiovascular disease (CVD) events but can cause some serious adverse events. We sought to develop and validate risk models for predicting absolute risk difference (increased risk or decreased risk) for CVD events and serious adverse eve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basu, Sanjay, Sussman, Jeremy B., Rigdon, Joseph, Steimle, Lauren, Denton, Brian T., Hayward, Rodney A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644999/ https://www.ncbi.nlm.nih.gov/pubmed/29040268 http://dx.doi.org/10.1371/journal.pmed.1002410

Ejemplares similares

Correction: Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials
por: Basu, Sanjay, et al.
Publicado: (2021)

Black-White Cardiovascular Disease Disparities After Target-Based Versus Personalized Benefit–Based Lipid and Blood Pressure Treatment
por: Basu, Sanjay, et al.
Publicado: (2017)

Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S.
por: Basu, Sanjay, et al.
Publicado: (2018)

Heterogeneity of Treatment Effects for Intensive Blood Pressure Therapy by Individual Components of FRS: An Unsupervised Data-Driven Subgroup Analysis in SPRINT and ACCORD
por: Wu, Yaqian, et al.
Publicado: (2022)

Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial
por: Ghazi, Lama, et al.
Publicado: (2023)

Erratum. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733–1738
por: Buckley, Leo F., et al.
Publicado: (2018)

Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program
por: Sussman, Jeremy B, et al.
Publicado: (2015)

In-Season Assessment of Sprint Speed and Sprint Momentum in Rugby Players According To the Age Category and Playing Position
por: Zabaloy, Santiago, et al.
Publicado: (2021)

Lowering systolic blood pressure does not increase stroke risk: an analysis of the SPRINT and ACCORD trial data
por: O'Conor, Ellen C., et al.
Publicado: (2018)

Machine learning with sparse nutrition data to improve cardiovascular mortality risk prediction in the USA using nationally randomly sampled data
por: Rigdon, Joseph, et al.
Publicado: (2019)

Research into the Health Benefits of Sprint Interval Training Should Focus on Protocols with Fewer and Shorter Sprints
por: Vollaard, Niels B. J., et al.
Publicado: (2017)

Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment
por: Aschmann, Hélène E, et al.
Publicado: (2019)

An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials
por: Sussman, Jeremy B, et al.
Publicado: (2010)

Intensive blood pressure treatment in coronary artery disease: implications from the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Zang, Jiabin, et al.
Publicado: (2021)

Intensive blood pressure control in patients with a history of heart failure: the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Pareek, Manan, et al.
Publicado: (2021)

Preventing false discovery of heterogeneous treatment effect subgroups in randomized trials
por: Rigdon, Joseph, et al.
Publicado: (2018)

Sprinting After Having Sprinted: Prior High-Intensity Stochastic Cycling Impairs the Winning Strike for Gold
por: Etxebarria, Naroa, et al.
Publicado: (2019)

Intensive Systolic Blood Pressure Treatment Remodels Brain Perivascular Spaces: A Secondary Analysis of SPRINT
por: Kern, Kyle C., et al.
Publicado: (2023)

Treatment of local–regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors
por: Wever, E M, et al.
Publicado: (2013)

Recovery benefits of using a heat and moisture exchange mask during sprint exercise in cold temperatures
por: Seifert, John G, et al.
Publicado: (2017)

Effect of Intensive and Standard Clinic‐Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT
por: Ghazi, Lama, et al.
Publicado: (2019)

Intensive systolic blood pressure treatment remodels brain perivascular spaces: A secondary analysis of the Systolic Pressure Intervention Trial (SPRINT)
por: Kern, Kyle C., et al.
Publicado: (2023)

Cancer immunotherapy: Benefit and harm?
por: Characiejus, Dainius
Publicado: (2012)

TRIOLOGY ACS: No benefit/No harm
por: Elmahdy, Mahmoud Farouk, et al.
Publicado: (2013)

Benefits and harms of mammography screening
por: Løberg, Magnus, et al.
Publicado: (2015)

Sprinting, Change of Direction Ability and Horizontal Jump Performance in Youth Runners According to Gender
por: Yanci, Javier, et al.
Publicado: (2017)

Validity of Critical Velocity Concept for Weighted Sprinting Performance
por: DICKS, NATHAN D., et al.
Publicado: (2018)

Energy compensation after sprint- and high-intensity interval training
por: Schubert, Matthew M., et al.
Publicado: (2017)

Visit‐to‐visit office blood pressure variability revisited in SPRINT
por: Nagai, Michiaki, et al.
Publicado: (2021)

Resting Heart Rate and Cardiovascular Outcomes during Intensive and Standard Blood Pressure Reduction: An Analysis from SPRINT Trial
por: Sobieraj, Piotr, et al.
Publicado: (2021)

Intensive Blood Pressure Control and Diabetes Mellitus Incidence for Patients with Impaired Fasting Glucose: A Secondary Analysis of SPRINT
por: Lin, Beiru, et al.
Publicado: (2023)

Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results
por: Huang, Chenxi, et al.
Publicado: (2017)

Repeated Sprint Ability and Muscular Responses According to the Age Category in Elite Youth Soccer Players
por: Sánchez-Sánchez, Javier, et al.
Publicado: (2019)

Muscular and Physical Response to an Agility and Repeated Sprint Tests According to the Level of Competition in Futsal Players
por: García-Unanue, Jorge, et al.
Publicado: (2020)

Differential Repeated Sprinting Training in Youth Basketball Players: An Analysis of Effects According to Maturity Status
por: Arede, Jorge, et al.
Publicado: (2022)

Critical Overview on the Benefits and Harms of Aspirin
por: Kwok, Chun Shing, et al.
Publicado: (2010)

Response to Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074
por: Hempe, James M., et al.
Publicado: (2015)

The Impact of Cognitive Function on the Effectiveness and Safety of Intensive Blood Pressure Control for Patients With Hypertension: A post-hoc Analysis of SPRINT
por: Yan, Jiafu, et al.
Publicado: (2021)

Validity of a Smartphone-Based Application for Determining Sprinting Performance
por: Stanton, Robert, et al.
Publicado: (2016)

Concurrent Validity and Reliability of the Sprint Force–Velocity Profile Assessed with K-AI Wearable Tech
por: Vantieghem-Nicolas, Laurine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ruke7pk1oqg1tg8vkb72qti480